A detailed history of State Of New Jersey Common Pension Fund D transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, State Of New Jersey Common Pension Fund D holds 44,755 shares of CRSP stock, worth $2.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
44,755
Previous 48,865 8.41%
Holding current value
$2.38 Million
Previous $3.06 Million 0.26%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$60.67 - $89.12 $249,353 - $366,283
-4,110 Reduced 8.41%
44,755 $3.05 Million
Q4 2023

Feb 02, 2024

SELL
$38.62 - $72.18 $117,366 - $219,355
-3,039 Reduced 5.86%
48,865 $3.06 Million
Q4 2022

Feb 01, 2023

BUY
$39.19 - $65.67 $132,893 - $222,686
3,391 Added 6.99%
51,904 $2.11 Million
Q2 2022

Aug 04, 2022

BUY
$43.23 - $73.83 $134,402 - $229,537
3,109 Added 6.85%
48,513 $2.95 Million
Q1 2022

May 03, 2022

BUY
$53.19 - $79.24 $333,128 - $496,280
6,263 Added 16.0%
45,404 $2.85 Million
Q4 2021

Jan 31, 2022

BUY
$70.09 - $111.29 $45,698 - $72,561
652 Added 1.69%
39,141 $2.97 Million
Q3 2021

Oct 27, 2021

SELL
$110.2 - $156.64 $4,959 - $7,048
-45 Reduced 0.12%
38,489 $4.31 Million
Q2 2021

Jul 23, 2021

BUY
$100.84 - $161.89 $194,419 - $312,123
1,928 Added 5.27%
38,534 $6.24 Million
Q1 2021

Apr 27, 2021

BUY
$110.72 - $210.04 $270,378 - $512,917
2,442 Added 7.15%
36,606 $4.46 Million
Q4 2020

Feb 03, 2021

SELL
$79.67 - $173.23 $222,996 - $484,870
-2,799 Reduced 7.57%
34,164 $5.23 Million
Q3 2020

Oct 27, 2020

BUY
$78.5 - $100.64 $467,781 - $599,713
5,959 Added 19.22%
36,963 $3.09 Million
Q2 2020

Aug 04, 2020

SELL
$38.5 - $76.05 $344,536 - $680,571
-8,949 Reduced 22.4%
31,004 $2.28 Million
Q4 2019

Jan 31, 2020

BUY
$36.68 - $73.13 $1.47 Million - $2.92 Million
39,953 New
39,953 $2.43 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.14B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.